Please login to the form below

Not currently logged in
Email:
Password:

chronic heart failure

This page shows the latest chronic heart failure news and features for those working in and with pharma, biotech and healthcare.

Real-world data finds patients feel better on Entresto, says Novartis

Real-world data finds patients feel better on Entresto, says Novartis

The drug was approved to treat chronic heart failure patients with reduced ejection fraction (HFrEF) or systolic dysfunction in 2015 and - after a sluggish start - finally seems to be developing sales ... s Jardiance (empagliflozin), as around a third of

Latest news

More from news
Approximately 4 fully matching, plus 45 partially matching documents found.

Latest Intelligence

  • A healthy challenge A healthy challenge

    Chronic diseases. One of the standout findings of the Health at a Glance report concerned the impact of chronic diseases in Europe. ... All told, 50 million people in the EU are afflicted by conditions such as diabetes, congestive heart failure, chronic

  • Pharma deals during July 2013 Pharma deals during July 2013

    Under this agreement, Servier has granted Amgen US rights to Procoralan (ivabradine), which is approved in Europe for chronic heart failure and stable angina in patients with elevated heart rates. ... Omecamtiv mecarbil is currently in phase II trials

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Enablers of drug innovation could lie in the numbers

    As drugs become more and more targeted, the need for this data is compounded, and information such as the whereabouts of the greatest concentration of patients with chronic heart failure, and ... a reduced ejection fraction within the New York Heart

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics